Treatment of idiopathic sclerosing inflammation of the orbit (myositis) with infliximab.
We report the successful use of infliximab in a young patient with idiopathic sclerosing orbital inflammation (myositis). We describe the patient's medical records and review the literature. Idiopathic myositis in this patient could not be satisfactorily treated with corticosteroids or chemotherapy. Biopsy showed sclerosing orbital inflammation. The patient had a prompt and sustained response with infliximab and methotrexate treatment. Infliximab and methotrexate might be considered in patients with idiopathic sclerosing orbital inflammation (myositis).